{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:05:35Z","timestamp":1772769935961,"version":"3.50.1"},"reference-count":190,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.lfs.2023.122124","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T16:08:31Z","timestamp":1695398911000},"page":"122124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Insights into the role of vitamin D in targeting the culprits of non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"332","author":[{"given":"Basma A.","family":"Abdelrahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiman S.","family":"El-Khatib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmeen M.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2023.122124_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0010","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1017\/S0029665119000570","article-title":"From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis","volume":"78","author":"Moore","year":"2019","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.lfs.2023.122124_bb0015","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/1389557518666181025153712","article-title":"Association between vitamin D levels and nonalcoholic fatty liver disease: potential confounding variables","volume":"19","author":"Pacifico","year":"2019","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.lfs.2023.122124_bb0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jhep.2023.05.003","article-title":"A call for unity: the path towards a more precise and patient-centric nomenclature for NAFLD","volume":"79","author":"EASL","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0025","article-title":"Non-alcoholic fatty liver disease: a patient guideline","volume":"3","author":"Francque","year":"2021","journal-title":"JHEP Rep."},{"key":"10.1016\/j.lfs.2023.122124_bb0030","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.cgh.2015.07.029","article-title":"Nonalcoholic fatty liver disease review: diagnosis, treatment, and outcomes","volume":"13","author":"Ahmed","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0035","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"150","author":"Machado","year":"2016","journal-title":"Gastroenterology."},{"key":"10.1016\/j.lfs.2023.122124_bb0040","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The global burden of liver disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hep4.1134","article-title":"Natural history of nonalcoholic fatty liver disease: a prospective follow-up study with serial biopsies","volume":"2","author":"Nasr","year":"2018","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.lfs.2023.122124_bb0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.lfs.2023.122124_bb0055","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"B\u00e4ckhed","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2023.122124_bb0060","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0036-1593880","article-title":"The metabolic role of the microbiome: implications for NAFLD and the metabolic syndrome","volume":"36","author":"Quigley","year":"2016","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.lfs.2023.122124_bb0065","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/10715762.2013.837577","article-title":"Involvement of free radicals and oxidative stress in NAFLD\/NASH","volume":"47","author":"Sumida","year":"2013","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.lfs.2023.122124_bb0070","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/medicina58050641","article-title":"Chronic inflammation\u2014a link between nonalcoholic fatty liver disease (NAFLD) and dysfunctional adipose tissue","volume":"58","author":"Petrescu","year":"2022","journal-title":"Medicina."},{"key":"10.1016\/j.lfs.2023.122124_bb0075","doi-asserted-by":"crossref","first-page":"20704","DOI":"10.3390\/ijms141020704","article-title":"Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)","volume":"14","author":"Takaki","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122124_bb0080","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology."},{"key":"10.1016\/j.lfs.2023.122124_bb0085","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0090","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.31420","article-title":"From NAFLD to MAFLD: implications of a premature change in terminology","volume":"73","author":"Younossi","year":"2021","journal-title":"Hepatology."},{"key":"10.1016\/j.lfs.2023.122124_bb0095","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.3390\/nu12113302","article-title":"Vitamin D and metabolic dysfunction-associated fatty liver disease (MAFLD): an update","volume":"12","author":"Barchetta","year":"2020","journal-title":"Nutrients."},{"key":"10.1016\/j.lfs.2023.122124_bb0100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.beem.2011.05.003","article-title":"Regulation of vitamin D metabolism","volume":"25","author":"Henry","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2023.122124_bb0105","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1172\/JCI106168","article-title":"\u201cActivation\u201d of vitamin D by the liver","volume":"48","author":"Ponchon","year":"1969","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2023.122124_bb0110","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/hep.26390","article-title":"Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association?","volume":"58","author":"Kwok","year":"2013","journal-title":"Hepatology."},{"key":"10.1016\/j.lfs.2023.122124_bb0115","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jhep.2012.04.033","article-title":"D-livering the message: the importance of vitamin D status in chronic liver disease","volume":"57","author":"Kitson","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101616","article-title":"Regulatory domains controlling high intestinal vitamin D receptor gene expression are conserved in mouse and human","volume":"298","author":"Fleet","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.122124_bb0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clinre.2011.02.003","article-title":"Vitamin D and the vitamin D receptor in liver pathophysiology","volume":"35","author":"Z\u00fa\u00f1iga","year":"2011","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.lfs.2023.122124_bb0130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1210\/jc.2008-1454","article-title":"Nonclassic actions of vitamin D","volume":"94","author":"Bikle","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2023.122124_bb0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1746.2005.03532.x","article-title":"Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese","volume":"20","author":"Fan","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0140","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1002\/jcp.26216","article-title":"Genetic and epigenetic factors influencing vitamin D status","volume":"233","author":"Bahrami","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2023.122124_bb0145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/ijpo.12293","article-title":"Vitamin D status and associated genetic polymorphisms in a cohort of UK children with non-alcoholic fatty liver disease","volume":"13","author":"Gibson","year":"2018","journal-title":"Pediatr. Obes."},{"key":"10.1016\/j.lfs.2023.122124_bb0150","doi-asserted-by":"crossref","first-page":"9122","DOI":"10.3390\/ijms23169122","article-title":"Vitamin D-related genetic variations and nonalcoholic fatty liver disease: a systematic review","volume":"23","author":"Jaroenlapnopparat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122124_bb0155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40360-021-00485-y","article-title":"The efficacy of calcitriol treatment in non-alcoholic fatty liver patients with different genotypes of vitamin D receptor FokI polymorphism","volume":"22","author":"Yaghooti","year":"2021","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2023.122124_bb0160","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1475-2891-12-96","article-title":"Relationship between vitamin D receptor gene polymorphisms and the components of metabolic syndrome","volume":"12","author":"Schuch","year":"2013","journal-title":"Nutr. J."},{"key":"10.1016\/j.lfs.2023.122124_bb0165","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology."},{"key":"10.1016\/j.lfs.2023.122124_bb0170","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3945\/jn.116.229963","article-title":"Vitamin D receptor gene polymorphisms are associated with abdominal visceral adipose tissue volume and serum adipokine concentrations but not with body mass index or waist circumference in African Americans: the Jackson Heart Study","volume":"146","author":"Khan","year":"2016","journal-title":"J. Nutr."},{"key":"10.1016\/j.lfs.2023.122124_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102141","article-title":"Vitamin D receptor gene polymorphisms are associated with obesity and inflammosome activity","volume":"9","author":"Al-Daghri","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.122124_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2018.12.022","article-title":"Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"51","author":"Arai","year":"2019","journal-title":"Digest. Liver Dis."},{"key":"10.1016\/j.lfs.2023.122124_bb0185","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.7666","article-title":"Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C","volume":"7","author":"Thanapirom","year":"2019","journal-title":"PeerJ."},{"key":"10.1016\/j.lfs.2023.122124_bb0190","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12957-019-1748-8","article-title":"Associations between twelve common gene polymorphisms and susceptibility to hepatocellular carcinoma: evidence from a meta-analysis","volume":"17","author":"Quan","year":"2019","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.lfs.2023.122124_bb0195","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jhep.2009.01.015","article-title":"Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations","volume":"50","author":"Tanaka","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0200","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2023.122124_bb0205","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The role of cholesterol in the pathogenesis of NASH","volume":"27","author":"Ioannou","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2023.122124_bb0215","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172575","article-title":"Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: a pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis","volume":"12","author":"Cannito","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.122124_bb0225","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0037-1604480","article-title":"Macrophages in nonalcoholic fatty liver disease: a role model of pathogenic immunometabolism","volume":"37","author":"Krenkel","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.lfs.2023.122124_bb0230","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fimmu.2017.00301","article-title":"Immunoregulatory role of NK cells in tissue inflammation and regeneration","volume":"8","author":"Tosello-Trampont","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2023.122124_bb0235","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0240","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3390\/nu12072097","article-title":"Immunologic effects of vitamin D on human health and disease","volume":"12","author":"Charoenngam","year":"2020","journal-title":"Nutrients."},{"key":"10.1016\/j.lfs.2023.122124_bb0245","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.3390\/ijms21186644","article-title":"The molecular mechanisms by which vitamin D prevents insulin resistance and associated disorders","volume":"21","author":"Szymczak-Pajor","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122124_bb0255","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.bbadis.2019.03.007","article-title":"Intestinal vitamin D receptor modulates lipid metabolism, adipose tissue inflammation and liver steatosis in obese mice","volume":"1865","author":"Jahn","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.lfs.2023.122124_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189707","article-title":"Effects of vitamin D on insulin resistance and myosteatosis in diet-induced obese mice","volume":"13","author":"Benetti","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.122124_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110564","article-title":"1,25D\/VDR inhibits pancreatic \u03b2 cell ferroptosis by downregulating FOXO1 expression in diabetes mellitus","volume":"105","author":"Ding","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2023.122124_bb0270","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.3390\/ijms23158465","article-title":"Vitamin D-VDR novel anti-inflammatory molecules-new insights into their effects on liver diseases","volume":"23","author":"Aggeletopoulou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122124_bb0275","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3390\/nu9091015","article-title":"Vitamin D supplementation and non-alcoholic fatty liver disease: present and future","volume":"9","author":"Barchetta","year":"2017","journal-title":"Nutrients."},{"key":"10.1016\/j.lfs.2023.122124_bb0280","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/hep.30937","article-title":"Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice","volume":"71","author":"Dong","year":"2020","journal-title":"Hepatology."},{"key":"10.1016\/j.lfs.2023.122124_bb0285","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2009.03.008","article-title":"Kupffer cells in non-alcoholic fatty liver disease: the emerging view","volume":"51","author":"Baffy","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0290","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes."},{"key":"10.1016\/j.lfs.2023.122124_bb0295","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science."},{"key":"10.1016\/j.lfs.2023.122124_bb0300","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri2378","article-title":"Vitamin effects on the immune system: vitamins A and D take centre stage","volume":"8","author":"Mora","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2023.122124_bb0305","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/rheumatology\/keq124","article-title":"Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes","volume":"49","author":"Dickie","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lfs.2023.122124_bb0310","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/rheumatology\/ken109","article-title":"Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet\u2019s disease","volume":"47","author":"Do","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lfs.2023.122124_bb0315","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jsbmb.2010.03.009","article-title":"Actions of vitamin D are mediated by the Tlr4 pathway in inflammation-induced colon cancer","volume":"121","author":"Murillo","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.lfs.2023.122124_bb0320","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/eji.200425995","article-title":"Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns","volume":"36","author":"Sadeghi","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lfs.2023.122124_bb0325","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.24552","article-title":"Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice","volume":"54","author":"Li","year":"2011","journal-title":"Hepatology."},{"key":"10.1016\/j.lfs.2023.122124_bb0330","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/362847","article-title":"Role of toll-like receptors and their downstream molecules in the development of nonalcoholic fatty liver disease","volume":"2010","author":"Miura","year":"2010","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.lfs.2023.122124_bb0335","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jsbmb.2013.02.005","article-title":"Vitamin D status and gene transcription in immune cells","volume":"136","author":"Mor\u00e1n-Auth","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.lfs.2023.122124_bb0340","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11154-021-09679-5","article-title":"Vitamin D, infections and immunity","volume":"23","author":"Ismailova","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.lfs.2023.122124_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179540","article-title":"Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: a randomized controlled pilot trial","volume":"12","author":"Carvalho","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.122124_bb0350","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3390\/biom11111624","article-title":"The effects of vitamin D on immune system and inflammatory diseases","volume":"11","author":"Ao","year":"2021","journal-title":"Biomolecules."},{"key":"10.1016\/j.lfs.2023.122124_bb0355","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4049\/jimmunol.179.3.1634","article-title":"Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation","volume":"179","author":"Chen","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2023.122124_bb0360","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41590-021-01080-3","article-title":"Autocrine Vitamin D-signaling switches off pro-inflammatory programs of Th1 cells","volume":"23","author":"Chauss","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2023.122124_bb0365","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells","volume":"167","author":"Boonstra","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2023.122124_bb0370","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1172\/JCI1050","article-title":"Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene","volume":"101","author":"D\u2019Ambrosio","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2023.122124_bb0375","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.clinre.2019.10.007","article-title":"Active vitamin D impedes the progression of non-alcoholic fatty liver disease by inhibiting cell senescence in a rat model","volume":"44","author":"Ma","year":"2020","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.lfs.2023.122124_bb0380","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1074\/jbc.RA119.011487","article-title":"Vitamin D receptor targets hepatocyte nuclear factor 4\u03b1 and mediates protective effects of vitamin D in nonalcoholic fatty liver disease","volume":"295","author":"Zhang","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.122124_bb0385","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1507\/endocrj.EJ16-0542","article-title":"Active form of vitamin D ameliorates non-alcoholic fatty liver disease by alleviating oxidative stress in a high-fat diet rat model","volume":"64","author":"Zhu","year":"2017","journal-title":"Endocr. J."},{"key":"10.1016\/j.lfs.2023.122124_bb0390","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.2337\/dc20-1765","article-title":"D2d research group, intratrial exposure to vitamin D and new-onset diabetes among adults with prediabetes: a secondary analysis from the Vitamin D and Type 2 Diabetes (D2d) study","volume":"43","author":"Dawson-Hughes","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2023.122124_bb0395","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jped.2020.08.006","article-title":"Vitamin D deficiency in children and adolescents with obesity: a meta-analysis","volume":"97","author":"Fiamenghi","year":"2021","journal-title":"J. Pediatr."},{"key":"10.1016\/j.lfs.2023.122124_bb0400","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1741-7015-9-85","article-title":"Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes","volume":"9","author":"Barchetta","year":"2011","journal-title":"BMC Med."},{"key":"10.1016\/j.lfs.2023.122124_bb0405","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.25930","article-title":"Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus","volume":"56","author":"Barchetta","year":"2012","journal-title":"Hepatology."},{"key":"10.1016\/j.lfs.2023.122124_bb0410","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.3748\/wjg.v23.i19.3407","article-title":"Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease","volume":"23","author":"Cimini","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2023.122124_bb0415","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4291\/wjgp.v10.i2.11","article-title":"Overview of studies of the vitamin D\/vitamin D receptor system in the development of non-alcoholic fatty liver disease","volume":"10","author":"Cimini","year":"2019","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"10.1016\/j.lfs.2023.122124_bb0420","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s13105-020-00764-y","article-title":"Metabolite profiling of mice under long-term fructose drinking and vitamin D deficiency: increased risks for metabolic syndrome and nonalcoholic fatty liver disease","volume":"76","author":"Li","year":"2020","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2023.122124_bb0425","doi-asserted-by":"crossref","DOI":"10.1097\/PG9.0000000000000077","article-title":"Relationship of vitamin D deficiency and fatty liver in children as defined by multiple imaging and histologic endpoints","volume":"2","author":"Rudolph","year":"2021","journal-title":"JPGN Rep."},{"key":"10.1016\/j.lfs.2023.122124_bb0430","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3892\/ijmm.2015.2300","article-title":"The effects of vitamin D3 on lipogenesis in the liver and adipose tissue of pregnant rats","volume":"36","author":"Kang","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2023.122124_bb0435","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/hep.24737","article-title":"Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation","volume":"55","author":"Roth","year":"2012","journal-title":"Hepatology."},{"key":"10.1016\/j.lfs.2023.122124_bb0440","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.dsx.2019.04.002","article-title":"Study of relationship between total vitamin D level and NAFLD in a sample of Egyptian patients with and without T2DM","volume":"13","author":"Hosny","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.lfs.2023.122124_bb0445","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/MCO.0000000000000605","article-title":"Vitamin D and nonalcoholic fatty liver disease","volume":"22","author":"Zhang","year":"2019","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.lfs.2023.122124_bb0450","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1017\/S095442242100038X","article-title":"NAFLD and vitamin D: evidence for intersection of microRNA-regulated pathways","volume":"36","author":"Zhang","year":"2023","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.lfs.2023.122124_bb0455","article-title":"Vitamin D supplementation for chronic liver diseases in adults","volume":"8","author":"Bjelakovic","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.lfs.2023.122124_bb0460","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7643542","article-title":"The level of vitamin D in children and adolescents with nonalcoholic fatty liver disease: a meta-analysis","volume":"2019","author":"Zhu","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2023.122124_bb0465","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4254\/wjh.v10.i1.142","article-title":"Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: a PRISMA compliant systematic review and meta-analysis of pooled data","volume":"10","author":"Saberi","year":"2018","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0470","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12020-014-0336-5","article-title":"Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial","volume":"47","author":"Sharifi","year":"2014","journal-title":"Endocrine."},{"key":"10.1016\/j.lfs.2023.122124_bb0475","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1039\/D0FO01095B","article-title":"Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials","volume":"11","author":"Guo","year":"2020","journal-title":"Food Funct."},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2023.122124_bb0480","doi-asserted-by":"crossref","first-page":"S975","DOI":"10.1016\/j.dsx.2017.07.025","article-title":"The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Tabrizi","year":"2017","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.lfs.2023.122124_bb0485","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0490","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122124_bb0495","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.3389\/fimmu.2017.01882","article-title":"Gut microbiota dysbiosis drives and implies novel therapeutic strategies for diabetes mellitus and related metabolic diseases","volume":"8","author":"Li","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2023.122124_bb0500","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/metabo12060514","article-title":"Interactions between tryptophan metabolism, the gut microbiome and the immune system as potential drivers of non-alcoholic fatty liver disease (NAFLD) and metabolic diseases","volume":"12","author":"Teunis","year":"2022","journal-title":"Metabolites."},{"key":"10.1016\/j.lfs.2023.122124_bb0505","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/apt.15314","article-title":"Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications","volume":"50","author":"Jayakumar","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2023.122124_bb0510","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","article-title":"The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)","volume":"76","author":"Safari","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2023.122124_bb0515","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00394-018-1844-5","article-title":"Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria","volume":"58","author":"Schwenger","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.lfs.2023.122124_bb0520","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.clinthera.2015.04.004","article-title":"Lack of vitamin D receptor causes dysbiosis and changes the functions of the murine intestinal microbiome","volume":"37","author":"Jin","year":"2015","journal-title":"Clin. Ther."},{"key":"10.1016\/j.lfs.2023.122124_bb0525","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3389\/fphys.2016.00498","article-title":"Vitamin D signaling through induction of Paneth cell defensins maintains gut microbiota and improves metabolic disorders and hepatic steatosis in animal models","volume":"7","author":"Su","year":"2016","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2023.122124_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105663","article-title":"Vitamin D and intestinal homeostasis: barrier, microbiota, and immune modulation","volume":"200","author":"Fakhoury","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.lfs.2023.122124_bb0535","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2017.31","article-title":"The role of vitamin D and vitamin D receptors in colon cancer","volume":"8","author":"Sun","year":"2017","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.lfs.2023.122124_bb0540","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3389\/fphys.2018.01813","article-title":"Intestinal microbiota modulation in obesity-related non-alcoholic fatty liver disease","volume":"9","author":"Porras","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2023.122124_bb0545","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s10620-015-3710-0","article-title":"Does vitamin D protect the gut mucosal barrier? Mechanistic insights from experimental colitis","volume":"60","author":"O\u2019Sullivan","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2023.122124_bb0550","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mce.2017.04.010","article-title":"Vitamin D signaling in intestinal innate immunity and homeostasis","volume":"453","author":"Dimitrov","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.lfs.2023.122124_bb0555","doi-asserted-by":"crossref","first-page":"106112","DOI":"10.1016\/j.intimp.2019.106112","article-title":"Vitamin D and microbiota: two sides of the same coin in the immunomodulatory aspects","volume":"79","author":"Malaguarnera","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2023.122124_bb0560","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neo.2016.10.007","article-title":"H19 overexpression induces resistance to 1,25(OH)2D3 by targeting VDR through miR-675-5p in colon cancer cells","volume":"19","author":"Chen","year":"2017","journal-title":"Neoplasia."},{"key":"10.1016\/j.lfs.2023.122124_bb0565","doi-asserted-by":"crossref","first-page":"G208","DOI":"10.1152\/ajpgi.00398.2007","article-title":"Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier","volume":"294","author":"Kong","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2023.122124_bb0570","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bbrc.2015.03.125","article-title":"1,25-Dihydroxyvitamin D3 preserves intestinal epithelial barrier function from TNF-\u03b1 induced injury via suppression of NF-kB p65 mediated MLCK-P-MLC signaling pathway","volume":"460","author":"Chen","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2023.122124_bb0575","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MIB.0000000000000282","article-title":"Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury","volume":"21","author":"Assa","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.lfs.2023.122124_bb0580","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.3748\/wjg.v26.i38.5812","article-title":"Is vitamin D receptor a druggable target for non-alcoholic steatohepatitis?","volume":"26","author":"Cao","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2023.122124_bb0585","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.bbagen.2012.09.020","article-title":"Implication of intestinal VDR deficiency in inflammatory bowel disease","volume":"1830","author":"Kim","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2023.122124_bb0590","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1248\/bpb.b20-00432","article-title":"A lipid-based nanocarrier containing active vitamin D3 ameliorates NASH in mice via direct and intestine-mediated effects on liver inflammation","volume":"43","author":"Mu","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.lfs.2023.122124_bb0595","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2147\/CEG.S262879","article-title":"Gut dysbiosis and increased intestinal permeability drive microRNAs, NLRP-3 inflammasome and liver fibrosis in a nutritional model of non-alcoholic steatohepatitis in adult male Sprague Dawley rats","volume":"13","author":"Longo","year":"2020","journal-title":"Clin. Exp. Gastroenterol."},{"key":"10.1016\/j.lfs.2023.122124_bb0600","article-title":"The sequence structures of human microRNA molecules and their implications","volume":"8","author":"Fang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.122124_bb0605","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41574-019-0260-0","article-title":"The clinical potential of circulating microRNAs in obesity","volume":"15","author":"Ji","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.lfs.2023.122124_bb0610","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","article-title":"MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases","volume":"70","author":"Wang","year":"2021","journal-title":"Gut."},{"key":"10.1016\/j.lfs.2023.122124_bb0615","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","article-title":"RNA in cancer","volume":"21","author":"Goodall","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2023.122124_bb0620","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1136\/gutjnl-2018-318146","article-title":"miRNAs and NAFLD: from pathophysiology to therapy","volume":"68","author":"Gjorgjieva","year":"2019","journal-title":"Gut."},{"key":"10.1016\/j.lfs.2023.122124_bb0625","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.addr.2018.01.009","article-title":"MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis","volume":"129","author":"Su","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.lfs.2023.122124_bb0630","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.619200","article-title":"Intake of natural compounds and circulating microRNA expression levels: their relationship investigated in healthy subjects with different dietary habits","volume":"11","author":"Ferrero","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122124_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118666","article-title":"MicroRNA-125a\/VDR axis impaired autophagic flux and contributed to fibrosis in a CCL4-induced mouse model and patients with liver cirrhosis","volume":"264","author":"He","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2023.122124_bb0640","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/ijms18020289","article-title":"Decreased expression of vitamin D receptor affects an immune response in primary biliary cholangitis via the VDR-miRNA155-SOCS1 pathway","volume":"18","author":"Kempinska-Podhorodecka","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122124_bb0645","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/17461391.2019.1635649","article-title":"Expression levels of selected cytokines and microRNAs in response to vitamin D supplementation in ultra-marathon runners","volume":"20","author":"Pastuszak-Lewandoska","year":"2020","journal-title":"Eur. J. Sport Sci."},{"key":"10.1016\/j.lfs.2023.122124_bb0650","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48081-9","article-title":"Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375\/oncogenes circuit","volume":"9","author":"Provvisiero","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.122124_bb0655","doi-asserted-by":"crossref","first-page":"35390","DOI":"10.18632\/oncotarget.15697","article-title":"Fine tuning of vitamin D receptor (VDR) activity by post-transcriptional and post-translational modifications","volume":"8","author":"Zenata","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.lfs.2023.122124_bb0660","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1097\/MIB.0000000000000158","article-title":"MicroRNA-346 mediates tumor necrosis factor-\u03b1-induced down-regulation of gut epithelial vitamin D receptor in inflammatory bowel diseases","volume":"20","author":"Chen","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.lfs.2023.122124_bb0665","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jsbmb.2010.02.003","article-title":"VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells","volume":"121","author":"Essa","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.lfs.2023.122124_bb0670","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/ijc.24459","article-title":"MicroRNA regulates human vitamin D receptor","volume":"125","author":"Mohri","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2023.122124_bb0675","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1124\/dmd.109.027680","article-title":"MicroRNAs regulate CYP3A4 expression via direct and indirect targeting","volume":"37","author":"Pan","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.lfs.2023.122124_bb0680","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.febslet.2009.01.034","article-title":"Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation","volume":"583","author":"Ji","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2023.122124_bb0685","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1124\/mol.109.056986","article-title":"Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b","volume":"76","author":"Komagata","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122124_bb0690","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nm.2584","article-title":"MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy","volume":"18","author":"Liu","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2023.122124_bb0695","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/jcb.22646","article-title":"Protection against cellular stress by 25-hydroxyvitamin D3 in breast epithelial cells","volume":"110","author":"Peng","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.lfs.2023.122124_bb0700","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1440-1746.2011.06892.x","article-title":"Hepatocellular carcinoma and vitamin D: a review","volume":"26","author":"Chiang","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0705","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/17474124.2018.1406307","article-title":"New insights into the role of vitamin D in hepatocellular carcinoma","volume":"12","author":"Wu","year":"2018","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0710","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/508989","article-title":"Vitamin D potentiates the inhibitory effect of microRNA-130a in hepatitis C virus replication independent of type I interferon signaling pathway","volume":"2015","author":"Duan","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.lfs.2023.122124_bb0715","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.28315v2","article-title":"Negative association of plasma levels of vitamin D and miR-378 with viral load in patients with chronic hepatitis B infection","volume":"15","author":"Mohamadkhani","year":"2015","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.lfs.2023.122124_bb0720","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.biopha.2018.08.153","article-title":"Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC","volume":"107","author":"Xu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2023.122124_bb0725","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jhep.2019.01.026","article-title":"Autophagy in liver diseases: time for translation?","volume":"70","author":"Allaire","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0730","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108863","article-title":"Autophagy in major human diseases","volume":"40","author":"Klionsky","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.lfs.2023.122124_bb0735","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/ars.2013.5371","article-title":"An overview of autophagy: morphology, mechanism, and regulation","volume":"20","author":"Parzych","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2023.122124_bb0740","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S1474-4422(18)30238-2","article-title":"Selective autophagy as a potential therapeutic target for neurodegenerative disorders","volume":"17","author":"Scrivo","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.lfs.2023.122124_bb0745","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/120179","article-title":"Autophagy and non-alcoholic fatty liver disease","volume":"2014","author":"Lavallard","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2023.122124_bb0750","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-981-10-8684-7_10","article-title":"Autophagy, NAFLD and NAFLD-related HCC","volume":"1061","author":"Wu","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2023.122124_bb0755","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nature07976","article-title":"Autophagy regulates lipid metabolism","volume":"458","author":"Singh","year":"2009","journal-title":"Nature."},{"key":"10.1016\/j.lfs.2023.122124_bb0760","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.3748\/wjg.v20.i23.7325","article-title":"Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue","volume":"20","author":"Kwanten","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2023.122124_bb0765","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/hep.28820","article-title":"Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice","volume":"64","author":"Tanaka","year":"2016","journal-title":"Hepatology."},{"key":"10.1016\/j.lfs.2023.122124_bb0770","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.162","article-title":"Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD","volume":"5","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2023.122124_bb0775","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.04.005","article-title":"Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance","volume":"11","author":"Yang","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2023.122124_bb0780","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ncb2718","article-title":"TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop","volume":"15","author":"Settembre","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.lfs.2023.122124_bb0785","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2013.01.011","article-title":"Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice","volume":"58","author":"Lin","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0790","doi-asserted-by":"crossref","DOI":"10.1080\/15548627.2020.1822088","article-title":"Vitamin D3-VDR-PTPN6 axis mediated autophagy contributes to the inhibition of macrophage foam cell formation","volume":"17","author":"Kumar","year":"2021","journal-title":"Autophagy."},{"key":"10.1016\/j.lfs.2023.122124_bb0795","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jsbmb.2017.02.007","article-title":"1,25-Dihydroxyvitamin-D3 prevents the development of diabetic cardiomyopathy in type 1 diabetic rats by enhancing autophagy via inhibiting the \u03b2-catenin\/TCF4\/GSK-3\u03b2\/mTOR pathway","volume":"168","author":"Wei","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.lfs.2023.122124_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108841","article-title":"Vitamin D in autophagy signaling for health and diseases: insights on potential mechanisms and future perspectives","volume":"99","author":"Bhutia","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.lfs.2023.122124_bb0805","first-page":"2630","article-title":"The role of 1,25-dyhydroxyvitamin D3 in mouse liver ischemia reperfusion injury: regulation of autophagy through activation of MEK\/ERK signaling and PTEN\/PI3K\/Akt\/mTORC1 signaling","volume":"7","author":"Yang","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.lfs.2023.122124_bb0810","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1136\/gutjnl-2014-307436","article-title":"Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis","volume":"64","author":"Wu","year":"2015","journal-title":"Gut."},{"key":"10.1016\/j.lfs.2023.122124_bb0815","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/15548627.2015.1034404","article-title":"Divergent roles of BECN1 in LC3 lipidation and autophagosomal function","volume":"11","author":"He","year":"2015","journal-title":"Autophagy."},{"key":"10.1016\/j.lfs.2023.122124_bb0820","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.metabol.2019.06.008","article-title":"LC3 promotes the nuclear translocation of the vitamin D receptor and decreases fibrogenic gene expression in proximal renal tubules","volume":"98","author":"Li","year":"2019","journal-title":"Metabolism."},{"key":"10.1016\/j.lfs.2023.122124_bb0825","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jid.2017.11.037","article-title":"Enhanced repair of UV-induced DNA damage by 1,25-dihydroxyvitamin D3 in skin is linked to pathways that control cellular energy","volume":"138","author":"Rybchyn","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0830","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/jc.2013-2103","article-title":"Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways","volume":"99","author":"Uberti","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2023.122124_bb0835","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/oby.21757","article-title":"1,25(OH)2 D3 attenuates hepatic steatosis by inducing autophagy in mice","volume":"25","author":"Li","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.lfs.2023.122124_bb0840","article-title":"Vitamin D receptor alleviates hepatic ischemia and reperfucion injury by mediating endoplasmic reticulum stress through autophagy","volume":"72","author":"Fang","year":"2021","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122124_bb0845","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3390\/ijms22041799","article-title":"Endoplasmic reticulum stress signaling and the pathogenesis of hepatocarcinoma","volume":"22","author":"Wei","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122124_bb0850","article-title":"Clinicopathologic charcterization of sorafenib-induced endoplasmic reticulum stress in human liver cancer cells","volume":"69","author":"Liu","year":"2018","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122124_bb0855","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s13679-021-00431-3","article-title":"Endoplasmic reticulum stress and autophagy in the pathogenesis of non-alcoholic fatty liver disease (NAFLD): current evidence and perspectives","volume":"10","author":"Flessa","year":"2021","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.lfs.2023.122124_bb0860","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1051\/jbio\/2020007","article-title":"ER stress and NAFLD","volume":"214","author":"Lachkar","year":"2020","journal-title":"Biol Aujourdhui."},{"key":"10.1016\/j.lfs.2023.122124_bb0865","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1051\/medsci\/2020008","article-title":"Endoplasmic reticulum stress response and pathogenesis of non-alcoholic steatohepatitis","volume":"36","author":"Vall\u00e9e","year":"2020","journal-title":"Med. Sci. (Paris)"},{"key":"10.1016\/j.lfs.2023.122124_bb0870","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.944088","article-title":"The pathogenesis of HCC driven by NASH and the preventive and therapeutic effects of natural products","volume":"13","author":"Shao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122124_bb0875","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1091\/mbc.E15-01-0036","article-title":"CHOP links endoplasmic reticulum stress to NF-\u03baB activation in the pathogenesis of nonalcoholic steatohepatitis","volume":"26","author":"Willy","year":"2015","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.lfs.2023.122124_bb0880","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.30887","article-title":"Vitamin D receptor activation in liver macrophages protects against hepatic endoplasmic reticulum stress in mice","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology."},{"key":"10.1016\/j.lfs.2023.122124_bb0885","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3389\/fimmu.2017.01299","article-title":"Hyperglycemia aggravates hepatic ischemia and reperfusion injury by inhibiting liver-resident macrophage M2 polarization via C\/EBP homologous protein-mediated endoplasmic reticulum stress","volume":"8","author":"Rao","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2023.122124_bb0890","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.freeradbiomed.2018.06.043","article-title":"IRE1\u03b1 aggravates ischemia reperfusion injury of fatty liver by regulating phenotypic transformation of kupffer cells","volume":"124","author":"Yang","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2023.122124_bb0895","doi-asserted-by":"crossref","first-page":"eabe2933","DOI":"10.1126\/sciimmunol.abe2933","article-title":"Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases","volume":"6","author":"Ren","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.lfs.2023.122124_bb0900","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-032521-102529","article-title":"Role of the inflammasome in liver disease","volume":"17","author":"Ribeiro","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.lfs.2023.122124_bb0905","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s10753-021-01439-6","article-title":"The signaling pathways regulating NLRP3 inflammasome activation","volume":"44","author":"Chen","year":"2021","journal-title":"Inflammation."},{"key":"10.1016\/j.lfs.2023.122124_bb0910","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0915","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0920","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/bph.14938","article-title":"Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-\u03baB pathway in mice","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122124_bb0925","doi-asserted-by":"crossref","first-page":"8525","DOI":"10.3748\/wjg.v20.i26.8525","article-title":"High fat diet feeding results in gender specific steatohepatitis and inflammasome activation","volume":"20","author":"Ganz","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2023.122124_bb0930","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","article-title":"Inflammasome activation and function in liver disease","volume":"12","author":"Szabo","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.122124_bb0935","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.toxlet.2019.08.024","article-title":"The protective effect of lithocholic acid on the intestinal epithelial barrier is mediated by the vitamin D receptor via a SIRT1\/Nrf2 and NF-\u03baB dependent mechanism in Caco-2 cells","volume":"316","author":"Yao","year":"2019","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.lfs.2023.122124_bb0940","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2018.09.037","article-title":"Vitamin D protects against diabetic nephropathy: evidence-based effectiveness and mechanism","volume":"845","author":"Hu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122124_bb0945","author":"Jiang"},{"key":"10.1016\/j.lfs.2023.122124_bb0950","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fphar.2020.00200","article-title":"Calcipotriol inhibits NLRP3 signal through YAP1 activation to alleviate cholestatic liver injury and fibrosis","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122124_bb0955","author":"Zhang"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523007592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523007592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T10:59:47Z","timestamp":1736333987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523007592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":190,"alternative-id":["S0024320523007592"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122124","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into the role of vitamin D in targeting the culprits of non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122124"}}